PT Sekar Bumi Tbk, (SKBM) Fair Value & Analysis
Consumer Defensive · ID · Market cap 934B IDR
Fair value as of: Jun 24, 2026
Analysis
PT Sekar Bumi Tbk, (SKBM) currently trades at 505.00 IDR, while our model-based Fair Value estimate is 689.26 IDR — implying the stock looks roughly 36.5% undervalued today. We read business quality at 91/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
PT Sekar Bumi Tbk, together with its subsidiaries, produces and sells frozen food products in Indonesia and internationally. The company operates in two segments, Value-Added Seafood and Processed Food. It offers raw, cooked, and value-added shrimp products; and frozen value-added seafood, frozen processed food, nuts, and seasonings. The company also engages in the production of shrimp and fish feeds; and shrimp farming business. In addition, it is involved in the wholesale trading of fishery and processed seafood products, beef, processed meat, and vegetables; other aquatic biota freezing activities; and cultivation of shrimp ponds. The company sells its products under the FINNA, SKB, Bumifood, Mitraku, and Freshmar brand names. It exports its products. The company was founded in 1973 and is headquartered in Jakarta Selatan, Indonesia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is PT Sekar Bumi Tbk, (SKBM) undervalued?
What is the fair value of SKBM?
What is the quality score of SKBM?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.